Agilent Technologies, Inc. (A)

Market Cap	44.11B +22.8%
Revenue (ttm)	7.37B +8.6%
Net Income	1.44B +18.0%
EPS	5.07 +18.4%
Shares Out	281.93M
PE Ratio	30.85
Forward PE	23.81
Dividend	$1.02 (0.65%)
Ex-Dividend Date	Oct 6, 2026

Volume	4,852,144
Open	156.00
Previous Close	156.34
Day's Range	154.60 - 156.73
52-Week Range	108.35 - 163.75
Beta	1.24
Analysts	Buy
Price Target	174.95 (+11.81%)
Earnings Date	Aug 26, 2026

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 18, 1999
• Employees: 18,100
• Stock Exchange: NYSE
• Ticker Symbol: A
• Website: https://www.agilent.com

Financial Performance

In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.

Analyst Summary

According to 23 analysts, the average rating for A stock is "Buy." The 12-month stock price target is $174.95, which is an increase of 11.81% from the latest price.

Price Target

$174.95

(11.81% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Sep 19, 2026

Data Sources Report a data error